GENESIS Tech Transfer Boost

Investment Vehicle

GENESIS Tech Transfer Boost is an investment vehicle created in 2022 and managed by the consulting firm GENESIS Biomed, with the aim of detecting and investing in early-stage projects in the biomedical sector from the ITEMAS Platform and the healthcare environment.

The founding partners are GENESIS Biomed, FI Group and Crowd4Ventures,  which are committing a total of €1M for the next 4 years. In addition, the total size of the vehicle can be increased by incorporating new partners in the coming months.

The creation of the investment vehicle will allow to identify projects in an ecosystem as solid as the ITEMAS Platform. In addition, they will be accompanied and managed from the early stages of the project, accelerating its arrival to the market.

The vehicle is positioned in the incubation area, targeting early-stage projects from the ITEMAS network and main healthcare centers. It is agnostic in the biomedical field, investing in projects that fit into the vehicle’s life cycle, in terms of medtech, diagnostic, biotech and digital.

Tickets ranging from €25,000 to €100,000 will be invested, depending on the nature of each project and its needs. The vehicle is allowed to invest in pre-foundation phase of the selected projects. The objective is to carry out the first investment before Summer of 2022.

GENESIS Biomed has validated the vehicle’s value proposition and investment model through a first vehicle, GENESIS Ventures, which has invested in 13 projects and has a portfolio valuation of x3.37 factor to date.

The main objective of the vehicle is to provide financial support to projects mainly from the ITEMAS Pratform, in order to follow these high impact projects to achieve effective transfer to the National Health System.

GENESIS Tech Transfer Boost
GENESIS Tech Transfer Boost
GENESIS Tech Transfer Boost
GENESIS Tech Transfer Boost